The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Fluticasone Furoate In The Treatment Of Copd - EP3650019

The patent EP3650019 was granted to Glaxosmithkline on Oct 11, 2023. The application was originally filed on May 27, 2015 under application number EP19214674A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3650019

GLAXOSMITHKLINE
Application Number
EP19214674A
Filing Date
May 27, 2015
Status
Granted And Under Opposition
Aug 4, 2023
Publication Date
Oct 11, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKJun 6, 2024ELKINGTON AND FIFEADMISSIBLE
SANDOZJun 6, 2024MAIWALDADMISSIBLE
TEVA PHARMACEUTICALSJun 6, 2024ELKINGTON AND FIFEADMISSIBLE

Patent Citations (4) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONWO2011067212
OPPOSITIONWO2012168161
OTHEREP3148521
SEARCHWO2011067212

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents